BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28421296)

  • 21. Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy.
    Arzt M; Gao B; Mozneb M; Pohlman S; Cejas RB; Liu Q; Huang F; Yu C; Zhang Y; Fan X; Jenkins A; Giuliano AE; Burridge PW; Cui X; Sharma A
    Stem Cell Reports; 2023 Oct; 18(10):1913-1924. PubMed ID: 37657447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs-a proof-of-concept study with doxorubicin.
    Pang L; Cai C; Aggarwal P; Wang D; Vijay V; Bagam P; Blamer J; Matter A; Turner A; Ren L; Papineau K; Srinivasasainagendra V; Tiwari HK; Yang X; Schnackenberg L; Mattes W; Broeckel U
    Toxicol Sci; 2024 Jun; 200(1):79-94. PubMed ID: 38547396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
    Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
    Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling trastuzumab-related cardiotoxicity in vitro using human stem cell-derived cardiomyocytes.
    Kurokawa YK; Shang MR; Yin RT; George SC
    Toxicol Lett; 2018 Mar; 285():74-80. PubMed ID: 29305325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
    Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
    Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
    Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
    Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity.
    Sharma A; McKeithan WL; Serrano R; Kitani T; Burridge PW; Del Álamo JC; Mercola M; Wu JC
    Nat Protoc; 2018 Dec; 13(12):3018-3041. PubMed ID: 30413796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
    Shinozawa T; Furukawa H; Sato E; Takami K
    J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.
    Burridge PW; Li YF; Matsa E; Wu H; Ong SG; Sharma A; Holmström A; Chang AC; Coronado MJ; Ebert AD; Knowles JW; Telli ML; Witteles RM; Blau HM; Bernstein D; Altman RB; Wu JC
    Nat Med; 2016 May; 22(5):547-56. PubMed ID: 27089514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes.
    Ulmer BM; Stoehr A; Schulze ML; Patel S; Gucek M; Mannhardt I; Funcke S; Murphy E; Eschenhagen T; Hansen A
    Stem Cell Reports; 2018 Mar; 10(3):834-847. PubMed ID: 29503093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Rampoldi A; Singh M; Wu Q; Duan M; Jha R; Maxwell JT; Bradner JM; Zhang X; Saraf A; Miller GW; Gibson G; Brown LA; Xu C
    Toxicol Sci; 2019 May; 169(1):280-292. PubMed ID: 31059573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes.
    Matsui T; Miyamoto K; Yamanaka K; Okai Y; Kaushik EP; Harada K; Wagoner M; Shinozawa T
    Toxicol Appl Pharmacol; 2019 Nov; 383():114761. PubMed ID: 31533062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells.
    Stillitano F; Karakikes I; Hajjar RJ
    Methods Mol Biol; 2017; 1521():183-193. PubMed ID: 27910049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosmarinic Acid as a Candidate in a Phenotypic Profiling Cardio-/Cytotoxicity Cell Model Induced by Doxorubicin.
    Zhang Q; Li J; Peng S; Zhang Y; Qiao Y
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32075047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Injured Hearts.
    Park KH; He X; Jiang L; Zhu H; Liang J; Wang Y; Ma J
    Stem Cell Rev Rep; 2023 Oct; 19(7):2420-2428. PubMed ID: 37477774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs.
    Adamcova M; Skarkova V; Seifertova J; Rudolf E
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc-induced metallothionein overexpression prevents doxorubicin toxicity in cardiomyocytes by regulating the peroxiredoxins.
    Jing L; Li L; Zhao J; Zhao J; Sun Z; Peng S
    Xenobiotica; 2016 Aug; 46(8):715-25. PubMed ID: 26599915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.